Drugs, Medical Devices, Biologics Archives - Page 32 of 38

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process
Gallery
Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process

Update Magazine | September/October 2017

Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Processadmin2017-11-16T13:49:39-05:00

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?
Gallery
The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?

Update Magazine | September/October 2017

The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?admin2017-11-16T13:49:48-05:00

The Changing Face of Marijuana Regulation: Current Federal Status
Gallery
The Changing Face of Marijuana Regulation: Current Federal Status

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017

The Changing Face of Marijuana Regulation: Current Federal Status

Update Magazine | September/October 2017

The Changing Face of Marijuana Regulation: Current Federal Statusadmin2017-11-16T13:53:40-05:00

India: Pharmaceutical Legal & Regulatory Environment
Gallery
India: Pharmaceutical Legal & Regulatory Environment

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017

India: Pharmaceutical Legal & Regulatory Environment

Update Magazine | September/October 2017

India: Pharmaceutical Legal & Regulatory Environmentadmin2017-11-16T14:19:35-05:00

Japan: A Better Environment
Gallery
Japan: A Better Environment

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017

Japan: A Better Environment

Update Magazine | September/October 2017

Japan: A Better Environmentadmin2017-11-16T14:19:42-05:00

How Can FDA Address the Opioid Addiction Crisis?
Gallery
How Can FDA Address the Opioid Addiction Crisis?

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update EXTRA, Update Magazine

How Can FDA Address the Opioid Addiction Crisis?

Update EXTRA | October 27, 2017

How Can FDA Address the Opioid Addiction Crisis?admin2018-11-30T11:54:12-05:00

Facing a Multiproduct Recall: Best Practices to Ensure Compliance with FDA Regulations and Pitfalls to Avoid
Gallery
Facing a Multiproduct Recall: Best Practices to Ensure Compliance with FDA Regulations and Pitfalls to Avoid

Archived Event, Drugs, Medical Devices, Biologics, Event, Food, Dietary Supplements, Cosmetics

Facing a Multiproduct Recall: Best Practices to Ensure Compliance with FDA Regulations and Pitfalls to Avoid

October 10, 2017 | Washington, DC

Facing a Multiproduct Recall: Best Practices to Ensure Compliance with FDA Regulations and Pitfalls to Avoidadmin2017-10-10T15:35:12-04:00

PDUFA and BsUFA Reauthorization: Key Changes Affecting Industry and Patients
Gallery
PDUFA and BsUFA Reauthorization: Key Changes Affecting Industry and Patients

Drugs, Medical Devices, Biologics, Event, Medical Products Webinars, On-demand Webinar

PDUFA and BsUFA Reauthorization: Key Changes Affecting Industry and Patients

Recorded September 12, 2017 | On-Demand Webinar

PDUFA and BsUFA Reauthorization: Key Changes Affecting Industry and Patientsadmin2024-07-19T09:42:22-04:00

Prescription Drug Advertising and Promotion Regulations and Enforcement in Select Global Markets
Gallery
Prescription Drug Advertising and Promotion Regulations and Enforcement in Select Global Markets

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update July/August 2017, Update Magazine

Prescription Drug Advertising and Promotion Regulations and Enforcement in Select Global Markets

Update Magazine | July/August 2017

Prescription Drug Advertising and Promotion Regulations and Enforcement in Select Global Marketsadmin2018-02-26T13:16:47-05:00

“Consistent Communications”: FDA’s Incremental Expansion of Promotional Bounds
Gallery
“Consistent Communications”: FDA’s Incremental Expansion of Promotional Bounds

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update July/August 2017, Update Magazine

“Consistent Communications”: FDA’s Incremental Expansion of Promotional Bounds

Update Magazine | July/August 2017

“Consistent Communications”: FDA’s Incremental Expansion of Promotional Boundsadmin2018-02-26T13:25:58-05:00